Published and unpublished comments on the PANDA trial

In September 2019 the following paper was published in the Lancet Psychiatry [the full open-access paper can be accessed here): Alongside the publication of the PANDA Trial in the Lancet … Continue reading Published and unpublished comments on the PANDA trial

Words and numbers should be used with equal care

I have submitted the following to the BMJ in response to this research news: Large meta-analysis ends doubts about efficacy of antidepressants Not uncommonly, as part of the scientific community, … Continue reading Words and numbers should be used with equal care

Antidepressant prescribing: still much to learn

The above meta-analysis was published in the Lancet today and I woke up to read headlines like this: The lead author, Andrea Cipriani, Department of Psychiatry, University of Oxford, was … Continue reading Antidepressant prescribing: still much to learn

Exposure to industry promotional activity can lead to doctors recommending worse treatments for patients

This is my BMJ Rapid Response, of the 6th January 2018 to Mike Thompson, CEO of the ABPI. [Association of the British Pharmaceutical Industry] I share Mike Thompson’s disappointment in some aspects … Continue reading Exposure to industry promotional activity can lead to doctors recommending worse treatments for patients